İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2025

Cognitive impairment in CKD patients: a guidance document by the CONNECT network.

Dergi

Clinical Kidney Journal

ISSN 2048-8505

YÖKSİS OpenAlex Açık erişim · gold SJR Q1 JCR Q1 Atıf 29 Üst %10 Yüzdelik 98.0% FWCI 6.74
Yıl
2025
Tür
article

Veri kaynağı ayrımı

  • YÖKSİS YÖKSİS makale kaydı
  • YÖKSİS dergi adı Clinical kidney journal
  • Katalog eşleşmesi (ISSN) Clinical Kidney Journal
  • OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

OpenAlex · İngilizce

Cognitive impairment is a prevalent and debilitating complication in patients with chronic kidney disease (CKD). This position paper, developed by the Cognitive Decline in Nephro-Neurology: European Cooperative Target network, provides guidance on the epidemiology, risk factors, pathophysiology, diagnosis and clinical management of CKD-related cognitive impairment. Cognitive impairment is significantly more common in CKD patients compared with the general population, particularly those undergoing haemodialysis. The development of cognitive impairment is influenced by a complex interplay of factors, including uraemic neurotoxins, electrolytes and acid-base disorders, anaemia, vascular damage, metabolic disturbances and comorbidities like diabetes and hypertension. Effective screening and diagnostic strategies are essential for early identification of cognitive impairment utilizing cognitive assessment tools, neuroimaging and circulating biomarkers. The impact of various drug classes, including antiplatelet therapy, oral anticoagulants, lipid-lowering treatments and antihypertensive drugs, on cognitive function is evaluated. Management strategies encompass pharmacological and non-pharmacological interventions, with recommendations for optimizing cognitive function while managing CKD-related complications. This guidance highlights the importance of addressing cognitive impairment in CKD patients through early detection, careful medication management and tailored therapeutic strategies to improve patient outcomes.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

29 atıf

OpenAlex cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 1 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. Tackling the interplay between the brain and kidneys: CYP2C19 mice as a preclinical tool for studying cognitive impairment in kidney disease? 2026 Atıf 0 · OpenAlex

Yazarlar

  1. Davide Balignano
  2. Mariadelina Simeoni
  3. GAYE HAFEZ KOÇ ÜNİVERSİTESİ
  4. Marion Pepin
  5. Antonio Gallo
  6. Manuela Altieri
  7. Sophie Liabeuf
  8. Konstantinos Giannakou
  9. Ananya De
  10. Giovambattista Capasso